Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebraska Symposium On Motivation. Nebraska Symposium On Motivation, 55, 31-63. https://doi.org/10.1007/978-0-387-78748-0_4 (Original work published 2009)
. BM Joyce
First name:
BM
Last name:
Joyce
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal Of Pharmacology And Experimental Therapeutics, 326(2), 563-76. https://doi.org/10.1124/jpet.108.136630
. (2008). Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). Biochemical Pharmacology, 74(8), 1271-82. https://doi.org/10.1016/j.bcp.2007.07.021 (Original work published 2007)
. (2007).